Testing version — LOERadar is in active testing. Features and data may change.
ERIBULIN MESYLATE (ERIBULIN MESYLATE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
ERIBULIN MESYLATE
ANDANot in Orange Book
ERIBULIN MESYLATE | A218930 | KINDOS
Products (1)
#001 — 1MG/2ML (0.5MG/ML)
▴
SOLUTION;INTRAVENOUS | Approved: Oct. 19, 2026
No patent or exclusivity listings for this strength.